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ABSTRACT
Objectives: High medication adherence is important for HIV suppression (antiretroviral therapy) and
pre-exposure prophylaxis efficacy. We are developing sensor-based technologies to detect pill-taking gestures,
trigger reminders, and generate adherence reports.
Materials and Methods: We collected interview, observation, and questionnaire data from individuals with and
at-risk for HIV (N ¼ 17). We assessed their medication-taking practices and physical actions, and feedback on
our initial design.
Results: While participants displayed diverse medication taking practices and physical actions, most (67%)
wanted to use the system to receive real-time and summative feedback, and most (69%) wanted to share data
with their physicians. Participants preferred reminders via the wrist-worn device or mobile app, and summative
feedback via mobile app or email.
Discussion: Adoption of these systems is promising if designs accommodate diverse behaviors and preferences.
Conclusion: Our findings may help improve the accuracy and adoption of the system by accounting for user
behaviors, physical actions, and preferences.
Key words: medication adherence, HIV infections, gestures, smartphone, human engineering

INTRODUCTION
“USE-MI” (Unobtrusive Sensing of Medication Intake) is a proofof-concept, low-cost, and innovative system designed to improve
medication-taking measurement and adherence. USE-MI employs a
wrist-worn device and a tagged medication container to unobtrusively sense individuals’ gestures related to opening a pill bottle followed by hand-to-mouth arm movement. It uses these data to detect
pill-taking behaviors, trigger pill-taking reminders to the wrist-worn

device, and a smartphone app if pill-taking is not detected, and generate summative data on individuals’ adherence levels. To guide the
design of this system, we conducted interviews with and observations of, and administered questionnaires to, individuals with and
at-risk for HIV. Our goal was to better understand individuals’ current medication-taking practices and technology preferences. Our
approach and findings may provide guidance for the development of
similar systems.

C The Author(s) 2018. Published by Oxford University Press on behalf of the American Medical Informatics Association.
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BACKGROUND AND SIGNIFICANCE
Studies of HIV treatment have demonstrated that durable viral suppression (the optimal outcome) requires consistently high adherence
(>90% of pills taken in previous 4 weeks) to antiretroviral therapy
(ART).1–3 Similarly, when antiretroviral medications are used as
pre-exposure prophylaxis (PrEP) in HIV-negative individuals, efficacy is highly dependent on adherence.4 For many patients, maintaining high levels of adherence is a challenge and, among both
HIV-positive and HIV-negative individuals, self-reported adherence
often overestimates adherence compared with more objective
indicators.5,6 For providers, lack of reliable, real-time information
about adherence makes it difficult to identify patients struggling
with adherence until adverse outcomes such as treatment resistance
or infection have occurred.
Issues around medication adherence extend well beyond ART
and PrEP, especially with respect to the management of other complex chronic diseases. Despite significant work developing and evaluating adherence-promoting interventions, Costa.7 noted in 2015
that the degree of non-adherence had not changed in the previous
decade. These adherence-promoting interventions include behavior
change, educational, integrated care, self-management, risk communication, and innovative packaging and reminders.7 The theories
and models on which these interventions are based are vast,
including—among others—behavioral learning theory, the health
belief model, social cognitive theory, theory of reasoned action, theory of planned behavior, transtheoretical model, and motivational
interviewing.8,9 Clearly, this is an area where significant work
remains.
The vast capabilities and low costs of wearable sensors make
them an increasingly viable technology for use in medication
adherence-promotion devices for HIV and other patient populations. But, these technologies alone are not sufficient. Any
adherence-promoting interventions using these sensors must be
based on known theoretical frameworks addressing adherencepromotion more generally. Additionally, research in the area of patient work shows that technology-based intervention outcomes are
affected by a complex and evolving sociotechnical system composed
of work structures and processes.10
The proposed sensor-based technologies may support more tailored reminders based on real-time, objective medication-intake
data. One research team member showed that a similar approach
could detect smoking gestures, and send real-time, tailored messages
to the individual.11 Their algorithm detected smoking gestures with
high accuracy (96%), precision (91%) and recall (81%).

MATERIALS AND METHODS
Participants (N ¼ 17) were recruited from two clinics providing
medical care and social services for persons living with and at-risk
for HIV in Seattle, WA, USA. In semi-structured face-to-face interviews, we asked participants questions about how they stored, took,
and remembered to take their medications and audio-recorded their
answers. We also elicited their feedback about how two candidate
devices (a Microsoft Band and a Sony Android Wear Watch) might
support this routine. We then video-recorded participants wearing a
wrist device, while taking placebo pills from a bottle. Participants
also independently completed an electronic questionnaire assessing
their perceived adherence levels, medication-taking practices, preferences for gaining feedback about their medication-taking patterns,
and general demographic measures. Interview responses and obser-
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vations were coded and reviewed by two team members. Questionnaire responses were analyzed using descriptive statistics. This study
was approved by the Swedish Medical Center IRB, and all subjects
gave consent for participation. Subjects were compensated with a
$50 grocery store gift card for their time. Table 1 shows how these
insights will guide the design of our system.

RESULTS
Shown in Table 2, almost all 17 participants were male, HIVpositive, and taking ART. Most were between 40 and 59 years old,
and they were relatively diverse in race/ethnicity. Fifteen of the seventeen participants responded via a visual analog scale what percentage
of their anti-HIV medications they think they took over the past 4
weeks.12,13 Participants reported taking a median of 95% (average ¼
88%) of their medications, although 40% of participants reported
taking <90% of pills taken in the previous 4 weeks (>90% is considered good). Participants reported taking HIV-related medications
once (82%) or twice (18%) per day. Almost all participants took
their medications in the morning or at night; only one participant
took medications at lunch. Participants reported taking their medications from pill bottles (29%), blister packs (6%), and “pill rolls” with
pills heat-sealed into bags labeled with the date and time of prescribed
administration (65%). Three participants (18%) reported deviating
from their normal method (eg, transferring containers because of
travel) five or more days a month. All participants reported taking
their medications with liquid; 35% with both liquid and food.
Participants used a range of medication reminder approaches, including placing the medications in visible locations (eg, by the coffee
pot) (29%), aspects of the storage method itself (eg, time and date
that were stamped on the heat-sealed bags in a “pill roll,”—
although some using “pill rolls” were unaware of the date/time
stamps on the bags) (12%), annotating calendars or other timerelated methods (29%), self-motivation or motivation from others
(24%), and eliciting reminders from others (6%).
Participants exhibited varied handedness, with 71% right-handed
(RH), 23% left-handed (LH), and 6% ambidextrous. When asked to
wear the wrist device and take a placebo pill from a bottle (even if
they typically took pills a different way), there was high variability in
which hands participants used to perform medication-taking tasks.
Figure 1 shows what hands participants used to complete each task,
separated by the participants’ handedness. Data for the ambidextrous
individual is not shown. A majority (75% of RH, 75% of LH) used
their right hand to turn the pill bottle cap. Participants were quite
evenly split (58.33/41.67% for RH, 50/50% for LH) in terms of which
hand they used to put the pill in their mouth. Most participants (83%
of RH, 75% of LH) used their dominant hand to drink the liquid.
After testing the devices, two participants (12%) stated they
would only wear the Microsoft Band and two (12%) stated they
would only wear the Android Wear Watch. Most participants
(76%) said they would use either device, although 70% of this
group preferred the Microsoft Band over the Android Wear Watch.
These preferences related to a variety of criteria, including size, comfort, durability, waterproofness to withstand sweating and showering at bathhouses, style, usability of the interface, other
functionality available, battery life, and the charging mechanism.
One participant did not want a valuable device that might be sold or
stolen (eg, to fund stimulant use).
Shown in Figure 2, participants were most interested in receiving
medication reminders via the wrist-worn device or a mobile app,
somewhat interested in receiving reminders via text messaging.

JAMIA Open, 2018, Vol. 1, No. 2

155

Table 1. Topics assessed and implications for system design
High-level topic

Sub-topic

How insights will guide design

Current
medication-taking
process

Perceived medication adherence

Which individuals should be targeted; USE-MI adoption may be higher among
poor adherers
What storage methods USE-MI may need to accommodate
Timing and frequency of gesture-recognition and reminders (affects algorithm
design and battery life)
Whether USE-MI will support or interfere with current reminder approaches
Whether the gesture detection algorithms should include liquid or food intake

Physical act of taking
medications
Feedback regarding
the USE-MI system

Current medication storage method
Schedule of medication-taking
Types of medication dose reminders
Whether medications are taken with liquid or food
Hand(s) used to complete medicationtaking actions
Preferences for two different wrist-worn
devices
Preferences for reminder method
Preferences for summative medicationtaking feedback method
Willingness to adopt the USE-MI system

Types of gestures needing to be recognized, preferred wrist for wearing device
Choice of wrist-worn device (Microsoft Band, Sony Android Wear Watch)
Choice of reminder method(s) (phone call, email, text, app, on wrist-worn device)
Choice of summative feedback method (email, portal, app) and recipient (self,
physician)
Tailor USE-MI to persons struggling with adherence to HIV-related medications

Table 2. Participant characteristics
Gender
Male
Female
Age range (years)
20–29
30–39
40–49
50–59
60–69
Unreported
Status
HIVþ taking ART
HIV taking PrEP
Race
White
Black
Multiracial
Prefer not to answer
Hispanic or Latino
Yes
No
Prefer not to answer

16
1
1
0
4
9
1
2
16
1
7
6
3
1
2
13
2

Reminders phone calls and e-mails were not of interest. Most participants (59%) wanted to receive feedback on their pill-taking over
time; most (69%) also wanted to share that information with their
doctor. Mobile apps (58%) and e-mail (33%) were the preferred
mechanisms for receiving this summative feedback. Overall, most
participants (67%) stated that they would like to use the system.
Some participants felt the feedback would be helpful, but either did
not want to wear the device or were concerned about the financial
cost of the device.

DISCUSSION
In this study of persons taking HIV-related medications, many
reported taking fewer than 90% of their pills in the previous 4
weeks (>90% is considered good) and most expressed interest in

using the system. This combination of clinical need and end-user interest provide support for potential adoption of the proposed system.
That said, participants displayed diverse behaviors and had varied
preferences for the proposed technologies. We discuss the implications
of our findings as they related to the technology form factors, gesturedetection functions, and end-user feedback approaches.
Our proof-of-concept design (Figure 3) employs three physical
form factors: a wrist-worn device, a smartphone app, and a small
motion-detection sensor attached to a pill bottle. Our initial proofof-concept design requires users to store their medications in pill
bottles, as the gestures related to opening a pill bottle are more distinct than opening other medication storage containers. However, in
the future we will need to determine how the system could accommodate medication boxes, blister packs, and heat-sealed bags. Our
initial system design uses a Microsoft Band—as it better supports
implementation of the gesture detection algorithms. Our observations suggest that being able to offer choice among form factors may
increase acceptability and adoption.
The observations, interviews and questionnaires gave us insight
into how the gesture-detection algorithms will need to function. The
timing of medications taken (one or twice/day, morning/night) was
quite consistent across participants, meaning that we can use this information to anticipate the timing of the gesture-detection and reminders.
The limited number of detection timeframes also has positive implications for the battery life of the gesture-detection sensors. The finding
that all individuals took their medications with liquid allows us the
possibility of adding this gesture to the detection algorithm. The significant variability in what hands individuals use to perform medicationtaking gestures presents a significant design challenge. Regardless of
handedness, most individuals turned the bottle cap with their right
hand, were evenly split on what hand they used to put the pill in their
mouth, and tended to drink water with their dominant hand. This finding suggests we cannot reliably detect medication taking using a single
gesture. The most complex scenario is a right-handed individual wearing the device on their left wrist, as they are unlikely to turn the bottle
cap or drink water with their left hand. For this group, a motiondetection sensor directly on the bottle is especially important.
Finally, there was some diversity in participants’ preferences for
system feedback mechanisms, namely how they receive
medication-taking reminders and summative reports. The current
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Figure 1. Hands used to complete medication-taking tasks.

Figure 2. Reminder preferences.

system design sends medication-taking reminders directly to the wristworn device and to the smartphone app (the two most preferred methods). Summative reports can be viewed from within the smartphone
app (the most preferred method). While these align with participants’
stated preferences, future iterations of the system will ideally allow
some flexibility in these methods. Participants also noted a desire to
share the summative reports with their physicians; the system will

therefore have the capacity to generate and send reports to the participants’ physicians.
While a large proportion of our sample of participants used pills
stored in heat-sealed bags (ie, “pill rolls”), we believe this practice is
uncommon based on a larger online survey (n ¼ 96) we conducted.
In that survey, 2% of respondents used pill rolls. This large proportion of our participants was likely due to two nearby community
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Figure 3. USE-MI system components.

pharmacies preferring to use pill rolls. We expect that in other populations, particularly for persons on PrEP, a higher portion of individuals would use pill bottles. Fifty-percent of PrEP survey respondents
used pill bottles. This is an important variable to assess in a potential
user population.
Our future work will include a pilot validation study, where participants will use the system for six months. This study will allow us
to better understand and improve the accuracy and efficiency of the
sensors and detection algorithms. We will also be able to understand
patterns of adoption and use of the system, including how we can redesign the system to make it more useful and usable.

CONCLUSION
To ensure adoption, interventions using sensor-based technologies
must account for user behaviors, physical actions, and preferences.
While we focused on designing an intervention for individuals with
and at risk for HIV, our findings may align with the preferences and
behaviors of patient populations with many other medical conditions for which medication adherence is critical.
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